key: cord-0999836-i3xxzzcm authors: Silva, A.; Aguirre, M. F.; Ballejo, C.; Marro, M. J.; GAMARNIK, A.; Vargas, G.; Pifano, M.; Varela, T.; Garcia, E.; Lawrynowicz, A.; Uez, O.; Pagano, I. title: Seroprevalence of the SARS-CoV-2 infection in health workers of the Sanitary Region VIII, at province of Buenos Aires date: 2020-09-09 journal: nan DOI: 10.1101/2020.09.07.20189050 sha: 0a19346e8df5fca663d57eb3800a1f387db56077 doc_id: 999836 cord_uid: i3xxzzcm Introduction: The aim of this study was to estimate the seroprevalence of the SARS-CoV-2 infection in health workers of the Sanitary Region VIII, at province of Buenos Aires during June 2020. Methods: a cross-sectional design was used. A probabilistic sampling by two-stage conglomerates was carried out. Data were collected from a self-administered questionnaire and a blood sample for antibody identification. The COVIDAR IgG and IgM test were used. RESULTS: 738 health workers were included; the overall response rate was 73.80%. 71.83% of that were women; age showed a normal distribution. Nurses and doctors accounted for more than half of the staff. 75.86% of people claimed to always use Personal Protective Equipment. 5.61% of people had close contact with a confirmed case of COVID-19. 4.60% of people had previously had a nasopharyngeal swab with a negative result. Five workers had positive IgG for SARS-CoV-2 (four women and one man) with negative IgM. The mean age of the cases was 35 years old; two of them were asymptomatic; neither of them had a swab sample taken. The overall seroprevalence was 0.75%, with no significant differences between strata. Discussion: the seroprevalence found was low; indicating a large proportion of workers was susceptible to infection. We stress the need to complement passive epidemiological surveillance strategies with serological monitoring in health workers. At the end of 2019, the world witnessed the emergence of a new disease. A hospital from Wuhan, Hubei province, alerted the Chinese government about the occurrence of a number of strange cases of severe pneumonia which were reported to the World Health Organization (WHO). The pathogen involved was identified as a novel outbreak of coronavirus 2019 (SARS-CoV-2). On January 30, the WHO declared the situation as a public health emergency of international concern and, on March 11, it was characterized as a pandemic 1 . COVID-19 pandemic, originated from infection of SARS-CoV-2, is significantly spreading around the world. Globally, on August 10, 2020, 19,718,030 cumulative cases and 728,013 deaths have been registered 2 . In Argentina, there were 253,868 confirmed cases and 4,785 deaths 3 . In this context, the situation of health care workers represents a topic of interest because they are in the first line of response and their exposure to the virus is high as well as their potential to spread the infection in the community. This type of workers faces unprecedented occupational risks of morbidity and mortality [4] [5] [6] [7] which makes the timely implementation of protective measures imperative for this group [8] [9] [10] . Health care workers are all those who provide health care services or whose job is to provide care services and who directly cooperate in assistance positions. This includes workers who are in charge of direct sick patient assistance (medical doctors, nurses, laboratory technicians, dentists, administrative workers, etc.) as well as those who are in charge of food, cleaning, maintenance and security services 9 . As of June 29, 2020, 9% (N=2,761) of confirmed cases of SARS-CoV-2 infection in Buenos Aires province involved health care workers 11 . The vast majority of the information available during the pandemic comes from passive epidemiological surveillance systems based on confirmation of suspected cases who have developed symptoms compatible with COVID-19. In this regard, the proportion of symptomatic infected individuals is mainly determined by RT-PCR from samples taken in nasopharyngeal and oropharyngeal swabs. The strategies based on serological tests that measure antibody response on the population have been widely implemented in epidemiological studies 12 . Antibodies against the virus develop days or weeks after the infection so their presence accounts for the previous exposure is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint to the virus and to the development of an immune response, regardless of the presence of symptoms. In this regard, the surveillance of antibody seropositivity as a public health strategy would allow us to reach to conclusions about the scope of the infection in a given population and the amount of asymptomatic individuals, and also, to detect cases that may have not been identified with passive surveillance strategies 13 . While many aspects regarding the duration and quality of the immune response to SARS-CoV-2 still need to be addressed, and considering that antibodies are markers of partial or total immunity, this type of studies could provide information as to which percentage of the population is susceptible to the virus 14 . In harmony with the WHO recommendations regarding the implementation of early response to the pandemic by means serological studies 15 , Buenos Aires province set up an active epidemiological surveillance strategy which includes the serological monitoring of health care workers. Within this framework, a seroprevalence study which started with a pilot test in public hospitals of the Sanitary Region (RS, by its acronym in Spanish) VIII of the province was carried out. The purpose was to estimate the SARS-CoV-2 infection seroprevalence on health care workers of the RS VIII public subsector in Buenos Aires province during June, 2020. A cross-sectional study was used. The target population was health care workers from public facilities from the RS VIII from Buenos Aires province during June, 2020. The RS VIII is located in the southeast of the province and encompasses 16 municipalities. The estimated population in 2010 was 1,150,290 inhabitants 16 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint provide the total number of workers from those 25 facilities. A total of 8,617 workers conformed the Secondary Sampling Units. In order to calculate the sample size, the population considered was the total number of workers from each facility. Regarding the proportion expected, the situation demanding the largest sample size was take into consideration (50%) With a confidence level of 95%, precision of 5% and design effect of 2, a sample size of 736 was obtained, but expanded to 1,000 participants in anticipation to a non-response rate possibility. Two strata were considered: I) interregional hospitals (2 facilities) II) regional, subregional, municipal, local hospitals and health care units with inpatient care (23 facilities). The sample was proportionately distributed among the strata according to their size. All units from stratum I were included. The workers were selected using simple random sampling in each unit. In stratum II, the sampling was carried out using two-stage cluster sampling; 50% of the units were selected using probabilities proportionate to their size. The sample was distributed between them with a fixed fraction for all clusters (15%). In this last stage, the allocation of subjects to the sampling was made on the basis of the workers list provided by the selected facilities. The order number was assigned to the corresponding worker according to their position on the list ranked alphabetically. All workers who signed an informed consent were included. Participants with contraindications for phlebotomy were excluded. Data collection was carried out by means of a self-administered paper questionnaire with three sections: health care worker identification (ID), symptoms history, and clinical history. Previously validated questions were included, they were taken from the COVID-19 Suspicious Case Notification Form of the National Ministry of Health 17 and from the risk assessment protocol for health care workers recommended by the WHO within the framework of early-response seroepidemiological investigations during the pandemic 10 . The recommendation to introduce an ethnic variable in the public health information system during COVID-19 was carried out in the pre-census joint design process with the National Institute of Statistics and Censuses (INDEC, by its acronym in Spanish) and the Network of Indigenous Professionals which was filed before the National Ministry of Health to promote the documentation of COVID-19 occurrences in indigenous populations 18 . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 9, 2020. . https://doi.org/10.1101/2020.09.07.20189050 doi: medRxiv preprint In case isotype IgG antibodies were detected, IgM would be determined using the COVIDAR IgM test (ANMAT PM 1545-5). If IgM was detected, the collection of a nasopharyngeal and oropharyngeal swab sample was indicated on the worker so as to rule out viral activity using RT-PCR. In such situation, the worker would be isolated and close contacts would be actively traced. A database was formulated using Epi Info TM (version 7) in order to upload the questionnaires and serological results. Fieldwork took place between June 3 and July 6, 2020. The questionnaires and the informed consents were sent in enclosed envelops and distributed in each facility on the vehicles used to transport the samples used in RS VIII. A previously designated representative from each hospital was in charge of inviting the selected workers, informing them about the study objectives, and organizing the assignment of data collection. The RS VIII administration contacted the municipal administration and health care departments of the facilities selected via videoconference, the study was presented, and operative concerns for implementation were established. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 9, 2020. . https://doi.org/10.1101/2020.09.07.20189050 doi: medRxiv preprint After the database clearance stage, 738 health care workers who complied with the blood test and filled in the questionnaire were included. The general response rate obtained was 73.80%. This number is nearly coincidental with the sample size calculated initially (736) that had been expanded to 1,000 participants in anticipation to a non-response rate possibility. Table 1 shows the response percentage per facility selected. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 9, 2020. . https://doi.org/10.1101/2020.09.07.20189050 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 9, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 9, 2020. . https://doi.org/10.1101/2020.09.07.20189050 doi: medRxiv preprint Only 5.61% knew they had close contact with a COVID-19 confirmed case (N= 478, CI: 5.15-6.12) 4.60% of the workers had been subjected to a nasopharyngeal swab at some point in time (N= 392, CI: 4.18-5.07), and all tested negative. Regarding the history of symptoms from the beginning of ASPO, headache was the most frequent (19.44%, n=147), followed by runny nose 10.49 % (n=76), less than 1% of the workers had fever (Table 3) . High blood pressure was the most frequent comorbidity on 11.65% of the workers (n=86); Diabetes mellitus was in second place (6.78%, n= 50) followed by asthma/COPD 6.10% is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 9, 2020. . https://doi.org/10.1101/2020.09.07.20189050 doi: medRxiv preprint during the ASPO. One person worked in another health care facility apart from the selected hospital. They all informed to have always used PPE. None of them had knowledge of having been in close contact with a confirmed case of coronavirus. They did not have history of relevant comorbidities. Two of them were asymptomatic. The symptoms informed by the remaining three cases were: headache, diminished sense of smell and taste, muscle aches, cold and runny nose. None of the five workers with positive IgG had been subjected to a nasopharyngeal swab, and did not informed having been in close contact with a confirmed case of COVID-19. The SARS-CoV-2 infection seroprevalence of health care workers in public hospitals with inpatient care whether it be general or specialized in maternal and child care of the RS VIII was 0.75% (CI: 0-8.13; standard error: 3.76). As per the strata, prevalence was 0.62% for interregional hospitals (CI: 0-9.82) and 0.82% (CI: 0-9.28) for regional, municipal, and local. To the best of our knowledge, this was the first seroepidemiological study on health care workers carried out in Argentina during the COVID-19 pandemic with health care workers from the public subsector in the first line of response to the infection. The prevalence detected was low, inferior to 1% with no significant difference between interregional hospitals and smaller ones. The findings of this investigation represent an important baseline to monitor the status of the pandemic. Four months after the emergence of the first cases in Argentina, less than one in one hundred health care workers of public hospitals have developed detectable antibodies for SARS-CoV-2. Aspects concerning the effectiveness and duration of the humoral immune response still remain to be determined, however, considering that the presence of IgG antibodies could be associated to a short-term protection, these findings call for attention to the fact that the majority of health care workers are still susceptible of being infected. This concern has been backed up by other seroprevalence studies carried out on the general public in countries that had even is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 9, 2020. . https://doi.org/10.1101/2020.09.07.20189050 doi: medRxiv preprint prevalence found. The apparent low risk of infection is in harmony with the scarce amount of workers who informed history of close contact with a confirmed case of COVID-19. In various countries around the world, the results of seroprevalence studies carried out during the COVID-19 pandemic on health care workers were dissimilar and inconsistent depending on the sampling strategy applied. It is interesting, however, that countries that experienced a rapid contagion curve with epidemics that collapsed the response capacity of the health care system have found relatively low prevalence results. Besides, it is well-known that the use of PPE lowers the infection risks health care workers are exposed to [26] [27] . In our study, a quarter of the workers informed not to have used it all the time. Such ratio should draw attention to the need to review the availability of PPE, training on its correct use, and investigation on aspects related to adherence to use. Another worth-mentioning aspect is multiple occupations of the health care workers which may be associated to a work overload. Not an insignificant percentage informed they worked at another facility besides the facility selected for the study. Previous investigations to this pandemic highlighted the work overload as an infection risk factor on health care workers 28 . In addition, this matter should be considered at the moment of planning epidemiological surveillance and outbreak studies during the pandemic because of the possibility of spreading the infection on diverse health centers if proper use of PPE is not reinforced. Even though the number of workers on whom antibodies were detected was low (five), two of them were asymptomatic. These findings, as well as the findings from other studies [29] [30] reinforce the need to harmonize passive epidemiological surveillance with serological surveillance on health care workers which may contribute to monitor the transmission dynamics and to evaluate infection control measures. This study has strengths and weaknesses. Regarding its strengths, we can highlight the random sampling strategy which allowed to get a direct measure of the infection dimension on one of the most vulnerable population groups during the pandemic. There was a high overall response rate which clearly shows the commitment of the individuals involved and also contributed to obtain reliable estimations. As of May 1 of this year, methodological biases were found in a systematic review of the SARS-CoV-2 seroprevalence results, mostly due to omission of random sampling in their target population. On the other hand, at this . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 9, 2020. . https://doi.org/10.1101/2020.09.07.20189050 doi: medRxiv preprint moment, which is almost synchronous with the preparation stage of this investigation field, only 14 countries in the world had reported seroprevalence results as part of completed or ongoing studies 25 . Regarding the weaknesses, the small amount of cases found did not allow to carry out an infection risk analysis according to different characteristics of the health care workers such as occupation or comorbidity history. The fieldwork done in order to obtain the required data for the sampling frame implied a great effort on the part of the research team since the information available was not integrated in only one database and had to be developed. In this regard, we highlight the need to improve the health care information systems in Argentina to allow for the possibility to access appropriate records. This investigation constitutes a baseline of the dimension of infection on health care workers in an area of Argentina with low viral transmission at the moment this work was carried out. The findings reinforce the importance of including this type of studies in the framework of active epidemiological surveillance strategies on vulnerable populations in order to monitor the infection tendency and the percentage of susceptible individuals. Cronología de la respuesta de la OMS a la COVID-19 World Health Organization Situación de COVID-19 en Argentina COVID-19 Risk Factors Among Health Workers: A Rapid Review. Safety and Health at Work Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers at the onset of the U.S. COVID-19 epidemic Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. The Lancet Public Health COVID-19 Evaluación de riesgos y manejo de trabajadores de la salud expuestos a COVID-19 Procedimiento de actuación para la prevención y control de casos de COVID-19 en el personal de salud Protocolo de evaluación de los posibles factores de Informe de situación del personal de salud al 29/06/2020. Dirección Provincial de Hospitales Antibody tests for identification of current and past infection with SARS-CoV-2 Cochrane Database of Systematic Reviews COVID-19 serology Surveillance Strategy Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, populationbased seroepidemiological study. The Lancet World Health Organization. Coronavirus disease (COVID-19) technical guidance: Early investigations protocols Gobierno de la provincia de Buenos Aires. Salud. Regiones sanitarias. Región sanitaria VIII Ficha de notificación, investigación epidemiológica y solicitud de estudios de laboratorio de caso sospechosos de nuevo coronavirus COVID-19 Tejido de Profesionales Indígenas en Argentina. Salud Intercultural. Incorporación de la variable étnica en el sistema de información de salud pública en tiempos Guía sobre la reglamentación relativa al transporte de sustancias infecciosas 2019-2020 Enzimoinmunoensayo (ELISA) para la detección de anticuerpos IgG específicos contra el virus SARS-CoV-2 en suero o plasma humano R: A Language and Environment for Statistical Computing Vienna, Austria: R Foundation for Statistical Computing Welcome to the tidyverse Tools for the Analysis of epidemiological Data. R package version 1 Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. The Lancet Lessons from a rapid systematic review of early SARS-CoV-2 serosurveys. Public and Global Health Impact of COVID-19 Outbreak on HealtRSre Workers in Italy: Results from a National E-Survey Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers: A Living Rapid Review Dual practice in the health sector: review of the evidence Serological tests facilitate identification of asymptomatic SARS-CoV-infection in Wuhan Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a secondary teaching hospital in Spain. medRxiv To the Hospital Directors included in the investigation and the representatives designated in